Global AI Patent Grants Top 100,000 for First Time as Agentic AI Filings Accelerate

On Tuesday, IFI CLAIMS Patent Services released its annual report on artificial intelligence patenting, IFI Insights: Inventing AI. According to the report, worldwide AI patent grants reached 107,279 in 2025, marking the first time the total has surpassed 100,000 in a single year. The figure also represents an 83% increase over the past three years. Globally, AI patent applications reached 209,518 in 2025, of which 23% related to generative AI and 9% related to agentic AI, which is up from 5% in IFI’s previous study.

UK Supreme Court Revives Tesla’s Claims That Avanci 5G Vehicle Pool License Doesn’t Satisfy FRAND Obligations

Yesterday, the UK Supreme Court issued a ruling in Tesla, Inc. v. InterDigital Patent Holdings, Inc. representing the latest development in UK jurisprudence surrounding fair, reasonable and non-discriminatory (FRAND) obligations on standard-essential patents (SEPs). Applying the reasoning of its landmark SEP decision in Unwired Planet, the UK Supreme Court revived Tesla’s claims that InterDigital’s SEPs to 5G vehicle communications technologies are not being offered on FRAND terms through Avanci’s patent pool and further upheld the jurisdiction of UK courts to decide global FRAND terms.

The Greatest Threat to IP Is Misunderstanding What It Does | IPWatchdog Unleashed

This week on IPWatchdog Unleashed, I speak with Martin Correa. Correa, who leads foresight work at the World Intellectual Property Organization (WIPO). Correa’s job is not to predict the future of IP, but to consider what futures are possible so WIPO and Member States can be better prepared for whatever eventuality does materialize. And since there is no data about the future—as he puts it—his work uses signals of change, horizon scanning and competing scenarios to expose assumptions and identify the decisions that could push the IP system in one direction or another.

Are Your Patent Assets Monetizable or Merely Countable?

Patent count is often the first thing people notice about a portfolio. It should not be the last. A portfolio with 500 patents may have little monetization value if the claims are difficult to understand, the infringing products are unclear, the damages are weak, the strongest assets are expired or expiring soon, or there are no pending applications. Conversely, a smaller portfolio with well-supported claims, identifiable infringing products, meaningful damages, remaining patent life, and pending applications in both the U.S. and Europe may be far more valuable.

Coke Stewart Leaving USPTO to Return to Private Sector

IPWatchdog has learned that U.S. Patent and Trademark Office (USPTO) Deputy Director Coke Morgan Stewart sent an email to USPTO executive staff today informing them that she will be leaving the Office to return to the private sector. Stewart reportedly told Secretary of Commerce Howard Lutnick and USPTO Director John Squires earlier today that she will be leaving by the end of this week.

CAFC Reverses Infringement Verdict, Finds Patent Owner’s Stent Coating Patent Invalid as Anticipated

The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision today reversing a jury verdict from the U.S. District Court for the District of Delaware that had found Boston Scientific Corporation (BSC) liable for infringing a patent owned by the Board of Regents of the University of Texas System (UT) covering drug-releasing biodegradable polymer fibers. The Federal Circuit concluded that BSC was entitled to judgment as a matter of law (JMOL) on both invalidity and non-infringement.

The Inventorship Squeeze: Invalidity, Unenforceability, and Why Prosecution Just Got More Expensive

In the space of a few months, the U.S. Court of Appeals for the Federal Circuit and the U.S. District Court for the District of Massachusetts delivered two decisions that, read together, change how patent applicants and their counsel should approach the deceptively simple question of who invented what. Fortress Iron, LP v. Digger Specialties, Inc., No. 2024-2313 (Fed. Cir. Apr. 2, 2026), holds that if an inventorship error cannot be corrected under 35 U.S.C. § 256, the patent is invalid — full stop, no intent required. Inline Plastics Corp. v. Lacerta Group, Inc., No. 1:18-cv-11631 (D. Mass. Nov. 13, 2025), holds that if an inventorship omission was intentional, the entire patent family is unenforceable for inequitable conduct — the Therasense penalty at full weight.

Varsity Sponsors

From the IPWatchdog Institute

Subscribe to IPWatchdog

This is the best way to stay informed. We send a daily roundup of our latest news, press releases, and events.

Get Email Updates